Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BND: Bromfenac vs Nepafenac vs Diclofenac in Cataract Surgery
NCT07178639Recruiting
- Sponsor
- Oblastní nemocnice Kolín
- Start
- Aug 2025
- Primary completion
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial in cystoid macular edema (CME) comparing bromfenac 0.09%, nepafenac 0.3% and diclofenac 0.1% (3 arms). Primary endpoint: Cystoid macular oedema presence at 6 weeks. Started Aug 2025; status: recruiting.
02
Drugs
bromfenac sodiumnepafenacdiclofenac
03
Conditions
cystoid macular edema (CME)
Beyond the preview
Go deeper on NCT07178639.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07178639.